Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Optimal timing of radiotherapy following radical prostatectomy

Prof Chris Parker - The Royal Marsden Hospital, London, UK
Optimal timing of radiotherapy following radical prostatectomy ( Prof Chris Parker - The Royal Marsden Hospital, London, UK )
4 Oct 2019

INVICTUS: Assessing the safety and efficacy of ripretinib in patients with advanced gastrointestinal stromal tumours

Prof Margaret von Mehren - Fox Chase Cancer Center, Philadelphia, USA
INVICTUS: Assessing the safety and efficacy of ripretinib in patients with advanced gastrointestinal stromal tumours ( Prof Margaret von Mehren - Fox Chase Cancer Center, Philadelphia, USA )
3 Oct 2019

Holistic management of patients with ALK-positive NSCLC

Rachel Thomas and Jackie Fenemore
Holistic management of patients with ALK-positive NSCLC ( Rachel Thomas and Jackie Fenemore )
3 Oct 2019

Precision medicine in ALK-positive NSCLC: Results from the BFAST trial

Prof Solange Peters and Prof Tony Mok
Precision medicine in ALK-positive NSCLC: Results from the BFAST trial ( Prof Solange Peters and Prof Tony Mok )
3 Oct 2019

Prostate cancer updates: Advances in precision medicine and PARP inhibitors

Prof Karim Fizazi, Dr Joaquin Mateo, Dr Shahneen Sandhu and Prof Bertrand Tombal
Prostate cancer updates: Advances in precision medicine and PARP inhibitors ( Prof Karim Fizazi, Dr Joaquin Mateo, Dr Shahneen Sandhu and Prof Bertrand Tombal )
2 Oct 2019

Health-related quality of life for patients with metastatic pancreatic cancer: Updates from ESMO 2019

Prof Eric Van Cutsem and Dr Teresa Macarulla
Health-related quality of life for patients with metastatic pancreatic cancer: Updates from ESMO 2019 ( Prof Eric Van Cutsem and Dr Teresa Macarulla )
2 Oct 2019

Role of molecular diagnostics in prostate cancer

Dr Elena Castro and Dr Shahneen Sandhu
Role of molecular diagnostics in prostate cancer ( Dr Elena Castro and Dr Shahneen Sandhu )
2 Oct 2019

Key developments in pancreatic cancer from ESMO 2019

Prof Eileen O'Reilly and Dr Ian Chau
Key developments in pancreatic cancer from ESMO 2019 ( Prof Eileen O'Reilly and Dr Ian Chau )
2 Oct 2019

Melanoma highlights from ESMO 2019

Dr Teresa Amaral - University Hospital Tübingen, Tübingen, Germany
Melanoma highlights from ESMO 2019 ( Dr Teresa Amaral - University Hospital Tübingen, Tübingen, Germany )
30 Sep 2019

IMvigor130: Immunotherapy added to chemotherapy in metastatic urothelial cancer

Dr Enrique Grande - Hospital MD Anderson Cancer Center Madrid, Madrid, Spain
IMvigor130: Immunotherapy added to chemotherapy in metastatic urothelial cancer ( Dr Enrique Grande - Hospital MD Anderson Cancer Center Madrid, Madrid, Spain )
30 Sep 2019

BEACON: Encorafenib plus cetuximab with or without binimetinib for BRAF V600E–mutant metastatic colorectal cancer

Prof Josep Tabernero - Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain
BEACON: Encorafenib plus cetuximab with or without binimetinib for BRAF V600E–mutant metastatic colorectal cancer ( Prof Josep Tabernero - Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain )
30 Sep 2019

Comment: Pembro plus chemo in neoadjuvant and adjuvant treatment for early triple-negative breast cancer

Prof Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia
Comment: Pembro plus chemo in neoadjuvant and adjuvant treatment for early triple-negative breast cancer ( Prof Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia )
29 Sep 2019